AEYE Health

🌟 AEYE Health & Optomed US: Joint Exhibitions at Two Upcoming Conferences! We’re thrilled to collaborate with Optomed US to showcase Aurora AEYE, the first FDA-cleared portable AI solution for diabetic eye exams. This cutting-edge technology allows for 1-minute, on-the-spot screenings during routine visits, delivering instant results without the need for dilation. With seamless integration into both clinical and home care settings, Aurora AEYE enhances access to care, helps close the diabetic eye exam care gap, and improves patient outcomes- plus, it’s reimbursable under CPT 92229. Join us at either event to explore how Aurora AEYE can transform your care delivery. We look forward to seeing you there! 📅 California Primary Care Association (CPCA) Conference 📍 Sacramento, CA | October 17-18 | Booth #220 📅 Book a demo here: https://lnkd.in/gkXTnq6X 📅 American Academy of Home Care Medicine (AAHCM) Annual Meeting 📍 Phoenix, AZ | October 18-19 | Booth #310 📅 Schedule a demo here: https://lnkd.in/g-x_nSGq #CPCA2024 #AAHCM2024 #AIinHealthcare #PortableAI #DiabeticEyeExams #AEYEHealth #OptomedUS

🌟 Exciting News! 🌟 AEYE Health will be at the American Academy of Ophthalmology (AAO) Annual Meeting in Chicago from October 18-21! Join us to discover AEYE-DS, our FDA-cleared AI technology that’s transforming retinal screening and improving patient outcomes. We’re excited to share how this cutting-edge solution is shaping the future of ophthalmology. Let’s connect! 📅 Email us at bd@aeyehealth.com to schedule a meeting. See you in Chicago! 👁️ #AAO2024 #AIinHealthcare #RetinalScreening #Ophthalmology #AEYEHealth

Thank you to everyone who visited us at the American Academy of Family Physicians FMX 2024! 🙌 It was a pleasure meeting so many of you and having meaningful discussions about how our FDA-cleared diabetic retinopathy screening technology can make a difference in your practice. 👁️💡 We’re excited about the future of family medicine and the role AI can play in closing diabetes care gaps, both in clinics and during home visits. Your insights and enthusiasm inspire us, and we’re looking forward to continuing the conversation. 💬✨ Stay connected, and let’s keep working together to enhance patient care! 👏 #AAFPFMX

🚀 Just one week to go until FMX 2024! We’re excited to announce that AEYE Health will be showcasing our cutting-edge, FDA-cleared AI diagnostic screening for diabetic retinopathy at the American Academy of Family Physicians FMX 2024! 🩺✨ Join us at Booth #2557 in Phoenix, AZ, from September 25-27 to experience our 1-minute AI diabetic retinopathy screening solution. Our solution provides on-the-spot results with just one image per eye, streamlining early detection and management without needing specialist involvement. ✨ Don’t miss your chance to witness this game-changing technology firsthand. Book an exclusive demo and see how our AI is revolutionizing diabetes care! Reserve your spot today: https://lnkd.in/gWnX2WPx #AAFPFMX

We're thrilled to announce that AEYE Health will be exhibiting at the American Academy of Family Physicians FMX 2024! Join us to experience our FDA-cleared AI diagnostic screening for diabetic retinopathy, delivering on-the-spot results at any point of care.🩺✨ Visit us at Booth #2557 from September 25-27 in Phoenix, AZ, and discover how our innovative AI screening is transforming diabetes care. With just one image per eye and instant AI diagnoses, our solution eliminates the need for specialist involvement, making early detection and management of diabetic retinopathy more accessible and efficient. ✨Don’t miss out—book an exclusive demo and see the future of diabetes care in action! Book your demo today: https://lnkd.in/gWnX2WPx

🎉 We’re honored to share that our CEO, Zack Dvey-Aharon, has been included in TIME’s 100 Most Influential People in Artificial Intelligence! Zack, Co-Founder of AEYE Health, was recognized for his dedication to advancing AI-driven healthcare. Under his leadership, AEYE Health’s Diagnostic Screening became the first FDA-cleared portable AI screening solution for diabetic retinopathy. This recognition reflects our ongoing commitment to improving patient care through innovative technology. And we’re just getting started. While diabetic retinopathy screening is a major milestone, we’re expanding our AI systems to screen for a range of other conditions, including cardiovascular disease, age-related macular degeneration, glaucoma, and hypertension. As Zack explains, retinal scans are incredibly valuable for medical diagnoses because the eyes can reveal so much about overall health. We’re grateful for the support and recognition and are excited to continue our journey of transforming healthcare. 🚀 https://lnkd.in/ejQTy8sM #AI #HealthcareInnovation #DiabeticRetinopathy #PatientCare #AIinHealth #TIME100AI #AIEyeCare #HealthTech

🎉 We’re honored to share that our CEO, Zack Dvey-Aharon, has been included in TIME’s 100 Most Influential People in Artificial Intelligence! Zack, Co-Founder of AEYE Health, was recognized for his dedication to advancing AI-driven healthcare. Under his leadership, AEYE Health’s Diagnostic Screening became the first FDA-cleared portable AI screening solution for diabetic retinopathy. This recognition reflects our ongoing commitment to improving patient care through innovative technology. And we’re just getting started. While diabetic retinopathy screening is a major milestone, we’re expanding our AI systems to screen for a range of other conditions, including cardiovascular disease, age-related macular degeneration, glaucoma, and hypertension. As Zack explains, retinal scans are incredibly valuable for medical diagnoses because the eyes can reveal so much about overall health. We’re grateful for the support and recognition and are excited to continue our journey of transforming healthcare. 🚀 https://lnkd.in/ejQTy8sM #AI #HealthcareInnovation #DiabeticRetinopathy #PatientCare #AIinHealth #TIME100AI #AIEyeCare #HealthTech

🔎 💫 Exciting Breakthrough in Diabetes Detection! Diabetes remains one of the leading causes of morbidity and mortality globally. But what if we could diagnose it using just a simple eye exam? In our latest publication, we reveal a groundbreaking AI-driven machine-learning model that can detect diabetes from retinal images in the absence of traditional diabetic eye disease indicators.  This innovative approach could revolutionize diabetes diagnosis, making it possible to detect the disease non-invasively at the point of care or in other accessible settings. Imagine the potential to identify many undiagnosed cases of diabetes and intervene sooner!  📑 Dive into the full study to explore how AI is paving the way for more accessible, early detection of diabetes 👉   https://lnkd.in/gEPzPdSE #DiabetesAwareness #AIinHealthcare #MachineLearning #HealthcareInnovation #DiabetesDetection

August is National Eye Exam Awareness Month! 👁 🔍 For people living with diabetes, regular eye exams are vital—especially for detecting diabetic retinopathy, the leading cause of blindness among working-age adults. Early detection is essential, but traditional screenings have often been inaccessible, resulting in less than 50% of patients adhering to annual screenings, leaving many at risk of preventable vision loss. This is where AI diagnostic screening solutions make a difference. With AEYE-DS, the only FDA-cleared autonomous AI screenings cleared with both a portable handheld camera and a robotic desktop camera, screenings can be performed at any point of care. Requiring a single image per eye, the solution produces a diagnostic result on-the-spot diagnoses without requiring specialist interpretation. This translates to quicker results, enhanced patient outcomes, and a more convenient, cost-effective experience for both patients and providers. ✨ Let’s work together to make diabetic retinopathy screenings as accessible as possible. By doing so, we can significantly reduce the burden of this preventable condition and promote better eye health for everyone. Visit our website to discover how AI is revolutionizing diabetic retinopathy screenings: https://lnkd.in/eyi-Z6Xm #EyeExamAwareness #DiabeticRetinopathy #AIHealthTech #PatientCare #HealthcareInnovation

Detect diabetic retinopathy in just 1 minute with AEYE-DS! ⏱️ Our AI diagnostic solution enables on-the-spot screening for diabetic retinopathy without physician interpretation, making the process fast, simple, and efficient. 🚀 AEYE-DS is the only technology that requires just one image per eye 👁️, and it's also the only FDA-cleared solution compatible with both a portable handheld camera and a tabletop robotic camera.  No matter the setting, AEYE-DS has you covered 🩺. Curious to see it in action? 📹 Watch our 1-minute, one-shot demo using the Topcon camera and experience the future of eye care! https://lnkd.in/gFTNVnhn